Marta-Gaia Zanchi is the Founder and Managing Partner of Nina Capital. See sector focus and contact routes.
Marta-Gaia Zanchi is the Founder and Managing Partner of Nina Capital, a Barcelona-based venture firm she launched in 2019 after 13 years in Silicon Valley, including a role as Founder and Director of Biodesign for Digital Health at Stanford’s Byers Center of Biodesign. She holds a Ph.D. in Electrical Engineering from Stanford and an MBA from IESE, and her investment thesis targets early-stage health tech and deeptech startups with global ambitions, focusing on pre-seed to Series A rounds in Europe and select U.S. companies. Nina Capital typically commits between $150,000 and just over $1 million as the first investor, often leading early rounds while reserving capital for follow-ons. Notable portfolio companies include Savana Médica, Medicsen, and Rivia, which received a $15 million Series A in March 2026. Zanchi emphasizes investing in “need-driven” founders who address specific healthcare challenges, stating the firm’s goal is to improve healthcare systems worldwide while delivering investor returns. She actively shares insights on scaling healthtech across Europe, including a October 2024 conference presentation on commercialization models fo
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Barcelona.
Investors like Marta-Gaia Zanchi · Full investor directory · Investor access · Company funding database